Major Drugmakers to Team Up in Court Against Price Negotiations

Four leading drugmakers seeking to scuttle Medicare’s drug pricing program will have their day in federal court Thursday to defend a gamut of legal challenges against the scheme.

Bristol Myers Squibb Co., Johnson & Johnson, Novartis AG, and Novo Nordisk A/S were given the green light from Judge Zahid N. Quraishi of the US District Court for the District of New Jersey to present their arguments in one hearing among the four separate lawsuits before the court.

The four-and-a-half hour long meeting will lay out the legal battle between the pharmaceutical industry ...